Last Price
342.69
Today's Change
+3.64 (1.07%)
Day's Change
337.19 - 342.73
Trading Volume
79,105
Exchange: NASDAQ Global Select NASDAQ Global Select
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. August James Troendle M.D. Dr. August James Troendle M.D.
Full Time Employees: 5,900 5,900
IPO Date: 2016-08-11 2016-08-11
CIK: 0001668397 0001668397
ISIN: US58506Q1094 US58506Q1094
CUSIP: 58506Q109 58506Q109
Beta: 1.37 1.37
Last Dividend: 0.00 0.00
Dcf Diff: -52.44 -52.44
Dcf: 395.13 395.13
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.